Skip to main content

Advertisement

Table 1 Clinical baseline characteristics compared with mean and peak leptin sample

From: Elevated serum leptin levels in patients with acute myocardial infarction; correlation with coronary angiographic and echocardiographic findings

Variables Mean Leptin Peak Leptin
  Normoleptinemia hyperleptinemia Normoleptinemia hyperleptinemia
  N = 13 (29.5%) N = 31 (70.4%) N = 5 (13.1%) N = 33 (86.8%)
Sex Male 11(84.6%) 31(100.0%) 4(80.0%) 32 (97.0%)
Female 2(15.4%) 0(0.0) 1(20.0%) 1(3.0%)
Age group ≤50 years 7(53.8%) 17(54.8%) 2(40.0%) 17 (51.5%)
>50 years 6(46.2%) 14(45.2%) 3(60.0%) 16 (48.5%)
Diabetic Yes 8(61.5%) 9(29.0%) 5(100.0%) 10 (30.3%)
No 5(38.5%) 22(71.0%) 0(0.0) 23 (69.7%)
Hypertensive Yes 4(30.8%) 5(16.1%) 1(20.0%) 6(18.2%)
No 9(69.2%) 26(83.9%) 4(80.0%) 27(81.8 %)
Body mass index (Kg/m2) <25 5(45.5%) 2(6.9%) 2(40.0%) 3(10.0%)
25-30 4(36.4%) 19(65.5%) 3(60.0%) 18(60.0%)
>30 2(18.2%) 8(27.6%) 0(0.0) 9(30.0%)
High Cholesterol >5.2 mmol/l Yes 5(38.5%) 4(12.9%) 1(20.0%) 7(21.2%)
  No 8(61.5%) 27(87.1%) 4(80.0%) 26(78.8%)
HDL* Abnormal (<1)mmolL 10(90.9%) 10(37.0%) 5(100.0%) 12(41.4%)
Normal(>1) mmol/L 1(9.1%) 17(63.0%) 0(0.0) 17(58.6%)
LDL ≤3.3 mmol/L 4(40.0%) 20(69.0%) 3(75.0%) 19(61.3%)
>3.3 mmol/L 6(60.0%) 9(31.0%) 1(25.0%) 12(38.7%)
Triglyceride ≤1.7 mmol/L 6(66.7%) 7(24.1%) 1(25.0%) 11(35.5%)
>1.7 mmol/L 3(33.3%) 22(75.9%) 3(75.0%) 20(64.5%)
MI type Anterior 8(66.7%) 19(61.3%) 4(80.0%) 19(59.4%)
Inferior 4(33.3%) 10(32.3%) 1(20.0%) 11(34.4%)
  Non ST Elevation 0(0.0) 2(6.5%) 0(0.0) 2(6.3%)
  1. Normo-leptinemia: serum leptin level for male = (3.8 ± 1.8 ng/ml), and for female (7.4 ± 3.7 ng/ml) with BMI range 18–25.
  2. Hyperleptinemia: serum leptin level > (3.8 ± 1.87 ng/ml) for males, for females > (7.4 ± 3.77 ng/ml) with BMI range 18–25.